New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ADI;CTRX;DISCA;EQIX;LBTYA;LMCA;REGN;SBAC;VRSK;WDC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
September 30, 2014
10:53 EDTREGNRegeneron dupilumab opportunity improved with new data, says Piper Jaffray
Piper Jaffray said it is increasingly optimistic about dupilumab's broad potential in allergic diseases following the Phase II data on chronic sinusitis with nasal polyps as well as prior data in atopic dermatitis and asthma. The firm views dupilumab as a potential blockbuster and reiterates its Overweight rating and $382 price target on Regeneron (REGN), which announced the data in partnership with Sanofi (SNY).
06:25 EDTDISCAFCC asks media companies for Comcast contract details, WSJ reports
The FCC is pushing for media companies to submit details of their programming agreements with Comcast (CMCSA) ahead of the company's merger with Time Warner Cable (TWC), reports the Wall Street Journal. Citing a person familiar with the matter, the FCC believes the documents contain information that would be relevant in its review. Officials from media companies including CBS (CBS), 21st Century Fox (FOXA), Disney (DIS), Discovery (DISCA), Time Warner (TWX) and Viacom (VIA;VIAB) met with FCC staff earlier this month to voice concerns about releasing highly confidential materials. Reference Link
05:16 EDTREGNRegeneron, Sanofi announce positive Phase 2 top-line dupilumab results
Regeneron Pharmaceuticals (REGN) and Sanofi (SNY) announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps, or CSwNP, who did not respond to intranasal corticosteroids. In the study, dupilumab resulted in a statistically-significant improvement in the size of nasal polyps, as measured by endoscopic Nasal Polyp Score, the primary endpoint of the study. Statistically significant improvements in all secondary efficacy endpoints were also observed, including objective measures of sinusitis by CT scan, nasal air flow, and patient-reported symptoms. In a pre-specified exploratory analysis, dupilumab-treated patients who also had asthma demonstrated significant improvements in asthma control. The safety profile was consistent with previous studies. The most common AEs with dupilumab were injection site reactions, nasopharyngitis, oropharyngeal pain, epistaxis, headache and dizziness.
September 29, 2014
09:56 EDTDISCADiscovery management to meet with Sterne Agee
Subscribe for More Information
08:13 EDTVRSKVerisk Analytics, EagleView update status of EagleView acquisition
Subscribe for More Information
08:04 EDTCTRXCatamaran shares now pricing in aggressive estimates, says Jefferies
Jefferies believes aggressive 2015 consensus earnings expectations are now adequately reflected in shares of Catamaran following the recent pullback. The firm continues to believe M&A will be a driver of shares in the near-term and that an upside-driving deal announcement is imminent. It keeps a Buy rating on Catamaran with a $58 price target.
08:02 EDTEQIXCisco announces partnership with Equinix
Subscribe for More Information
07:26 EDTREGNInforma Business Information to hold a conference
Subscribe for More Information
September 26, 2014
09:47 EDTADIAnalog Devices management to meet with Pacific Crest
Subscribe for More Information
06:31 EDTCTRXCatamaran 'mega' deal likely over next few years, says Leerink
Subscribe for More Information
September 25, 2014
08:59 EDTREGNSummer Street chief scientific officer holds an analyst/industry conference call
Subscribe for More Information
08:15 EDTADIAnalog Devices management to meet with Deutsche Bank
Meeting to be held in Frankfurt on September 25 hosted by Deutsche Bank.
08:05 EDTCTRXCatamaran risk/reward compelling after pullback, says FBR Capital
FBR Capital attributes yesterday's weakness in shares of Catamaran to concerns from the consultant community regarding service issues and competition. The firm says its not aware of any "widespread" evidence pointing to performance issues at the company. It views the risk/reward scenario on shares of Catamaran as compelling and maintains an Outperform rating on the name.
07:16 EDTDISCADiscovery confirms deal with Hasbro to increase stake in Hub jv to 60%
Subscribe for More Information
September 24, 2014
09:17 EDTDISCAComcast accuses TWC deal opponents of extortion, Re/code reports
Subscribe for More Information
08:21 EDTADIAnalog Devices management to meet with Deutsche Bank
Subscribe for More Information
September 23, 2014
10:32 EDTDISCA, LBTYADiscovery, Liberty Global close deal to acquire All3Media
Subscribe for More Information
10:02 EDTEQIX, ADIOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Analog Devices (ADI) downgraded to Neutral from Overweight at JPMorgan... Bed Bath & Beyond (BBBY) downgraded to Market Perform at William Blair... Cameco (CCJ) downgraded to Neutral from Buy at BofA/Merrill... Clorox (CLX) downgraded to Neutral from Buy at Citigroup... Concur (CNQR) downgraded to Neutral from Buy at Roth Capital... Del Frisco's (DFRG) downgraded at Sterne Agee... Dick's Sporting (DKS) downgraded to Market Perform from Outperform at William Blair... Dresser-Rand (DRC) downgraded to Hold from Buy at KeyBanc... Equinix (EQIX) downgraded to Market Perform from Outperform at Wells Fargo... Fluor (FLR) downgraded at Wells Fargo... Gordmans Stores (GMAN) downgraded at Canaccord... Jacobs Engineering (JEC) downgraded to Market Perform from Outperform at Wells Fargo... Nanometrics (NANO) downgraded to Hold from Buy at Canaccord... ON Semiconductor (ONNN) downgraded to Neutral from Overweight at JPMorgan... Siemens (SIEGY) downgraded to Equal Weight from Overweight at Barclays... Sigma-Aldrich (SIAL) downgraded to Hold from Buy at KeyBanc... Taminco (TAM) downgraded to Hold from Buy at Jefferies... Viasystems (VIAS) downgraded to Hold from Buy at Canaccord... Watsco (WSO) downgraded to Accumulate from Buy at Global Hunter.
07:54 EDTCTRXLeerink to hold a conference
Subscribe for More Information
07:52 EDTADIAnalog Devices management to meet with Deutsche Bank
Meeting to be held in London on September 23 hosted by Deutsche Bank.
07:38 EDTCTRXCantor to hold a conference
3rd Annual Technology Conference to be held in Toronto on September 23.
07:38 EDTCTRXCatamaran high EBITDA estimates could create overhang, says Credit Suisse
Subscribe for More Information
06:32 EDTADIAnalog Devices downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Analog Devices to Neutral saying its expectation for increasing leverage has not materialized. The firm keeps a $60 price target for shares.
05:28 EDTEQIXEquinix downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
September 22, 2014
09:38 EDTADIAnalog Devices management to meet with Deutsche Bank
Meeting to be held in London on September 22 hosted by Deutsche Bank.
07:25 EDTADICitigroup to hold a conference
Industrials Conference to be held in Boston on September 22-24.
05:17 EDTREGNRegeneron announces EYLEA injection approved for myopic CNV treatment in Japan
Subscribe for More Information
September 18, 2014
10:00 EDTDISCAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abengoa Yield (ABY) initiated with a Neutral at Macquarie... Acacia Research (ACTG) initiated with an Outperform at Northland... Alibaba (BABA) initiated with a Buy at CRT Capital... Allianz (AZSEY) initiated with a Buy at UBS... Boulder Brands (BDBD) initiated with a Neutral at Piper Jaffray... Brookfield Renewable (BEP) initiated with an Outperform at Macquarie... Cogent (CCOI) initiated with an Overweight at JPMorgan... Discovery (DISCA) initiated with a Buy at Argus... FCB Financial (FCB) initiated with a Market Perform at Keefe Bruyette... Five Oaks (OAKS) initiated with a Buy at Ladenburg... Furmanite (FRM) initiated with a Buy at Sidoti... Fusion Telecommunications (FSNN) initiated with a Buy at H.C. Wainwright... Helen of Troy (HELE) initiated with an Overweight at Piper Jaffray... ICON plc (ICLR) initiated with a Buy at KeyBanc... InterOil (IOC) initiated with an Outperform at Credit Suisse... Jarden (JAH) initiated with an Overweight at Piper Jaffray... Level 3 (LVLT) initiated with an Overweight at JPMorgan... Lombard Medical (EVAR) initiated with a Buy at BTIG... NRG Yield (NYLD) initiated with an Outperform at Macquarie... Newell Rubbermaid (NWL) initiated with a Neutral at Piper Jaffray... NextEra Energy Partners (NEP) initiated with an Outperform at Macquarie... Novatel Wireless (NVTL) initiated with a Buy at H.C. Wainwright... Parker-Hannifin (PH) initiated with a Hold at Deutsche Bank... Pattern Energy (PEGI) initiated with a Neutral at Macquarie... Rentrak (RENT) initiated with a Buy at Wunderlich... Rhino Resources (RNO) initiated with a Buy at Ladenburg... Ryerson (RYI) initiated with a Buy at KeyBanc... SFX Entertainment (SFXE) initiated with a Buy at Maxim... SoftBank (SFTBY) initiated with a Buy at Jefferies... Sprouts Farmers Markets (SFM) initiated with a Neutral at Piper Jaffray... TerraForm Power (TERP) initiated with an Outperform at Macquarie... Vince Holding (VNCE) initiated with a Buy at B. Riley... WhiteWave Foods (WWAV) initiated with an Overweight at Piper Jaffray.
07:34 EDTDISCADiscovery initiated with a Buy at Argus
Subscribe for More Information
September 17, 2014
15:03 EDTDISCADiscovery near deal with Hasbro for control of 'The Hub' jv, WSJ says
Subscribe for More Information
14:29 EDTDISCADiscovery near deal with Hasbro for control of 'The Hub' jv, DJ says
Subscribe for More Information
09:04 EDTDISCAAmericas Media ad growth estimates lowered at Nomura
Subscribe for More Information
September 16, 2014
07:31 EDTREGNRegeneron's EYLEA Injection granted designation for treatment of retinopathy
Subscribe for More Information
07:27 EDTDISCABofA/Merrill to hold a conference
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use